CMChristopher Madden

Christopher Madden

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Christopher Madden has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Spectrophotometric determination of LAP photoinitiator radicalization in ophthalmic applications

    by Peter A Jansen, Vedshree Deshmukh, Poulami Ghosh, Sanjusha Gudla, Arnav Madani, Issac Reynaga, Christopher Madden, Heather L Chandler, Cynthia J Roberts, Katelyn E Swindle-Reilly

    The incidence of lamellar corneal transplantations is increasing. While a human donor cornea could potentially be used for up to two recipients, one anterior and one posterior part, it does not change the disparity between available donor grafts and patients needing corneal transplants. Additionally, donor grafts carry the risk of graft rejection due to foreign cellular material and disease transmission. We have investigated acellular synthetic graft materials to eliminate these drawbacks using hydrogel materials and the extrusion bioprinting process. To create these materials with higher moduli, the photocrosslinking process has advantages but needs an appropriate crosslinker material. We have shown that we can determine the presence of the non-radicalized crosslinker lithium phenyl (2,4,6-trimethylbenzoyl) phosphinate (LAP) with spectrophotometric methods, using the crosslinker absorbance characteristics. To show non radicalized LAP the measurement is done at 372 nm, and the measured absorbance level depends on the LAP concentration. This allows for a simple evaluation of crosslinked hydrogels to determine any remaining non radicalized LAP and with that potential cytotoxic or other effects of this crosslinking material to correct this situation if necessary.


  • Top Cited Papers

    SARS-CoV-2 infection in free-ranging white-tailed deer

    by Vanessa L. Hale, Patricia M. Dennis, Dillon S. McBride, Jacqueline M. Nolting, Christopher Madden, Devra Huey, Margot Ehrlich, Jennifer Grieser, Jenessa Winston, Dusty Lombardi, et al.

    Humans have infected a wide range of animals with SARS-CoV-21,2,3,4,5, but the establishment of a new natural animal reservoir has not been observed. Here we document that free-ranging white-tailed deer (Odocoileus virginianus) are highly susceptible to infection with SARS-CoV-2, are exposed to multiple SARS-CoV-2 variants from humans and are capable of sustaining transmission in nature. Using real-time PCR with reverse transcription, we detected SARS-CoV-2 in more than one-third (129 out of 360, 35.8%) of nasal swabs obtained from O. virginianus in northeast Ohio in the USA during January to March 2021. Deer in six locations were infected with three SARS-CoV-2 lineages (B.1.2, B.1.582 and B.1.596). The B.1.2 viruses, dominant in humans in Ohio at the time, infected deer in four locations. We detected probable deer-to-deer transmission of B.1.2, B.1.582 and B.1.596 viruses, enabling the virus to acquire amino acid substitutions in the spike protein (including the receptor-binding domain) and ORF1 that are observed infrequently in humans. No spillback to humans was observed, but these findings demonstrate that SARS-CoV-2 viruses have been transmitted in wildlife in the USA, potentially opening new pathways for evolution. There is an urgent need to establish comprehensive ‘One Health’ programmes to monitor the environment, deer and other wildlife hosts globally.